You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 26, 2024

Details for Patent: 6,342,530


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,342,530
Title: Composition and method for parenteral administration of ibuprofen d,l- or l-lysine salt
Abstract:Pharmaceutical compositions are disclosed suitable for parenteral administration having anti-inflammatory, analgesic, and anti-pyretic properties, which consist of a therapeutically effective amount of d,l or l-lysine salt of R,S or S-ibuprofen as active ingredient dissolved in sterile water to form a solution in the absence of an inert atmosphere and either substantially free or absolutely free of any excipient, organic solvent, buffer, acid, base, salt other than the active ingredient and capable of storage in the absence of an inert atmosphere. Also disclosed are methods employing the new compositions in the treatment of pain and inflammation, in reducing fever and in treating patent ductus arterious or intraventricular hemorrhage in prematurely born neonates.
Inventor(s): Darko; Laszlo (Westport, CT)
Assignee: Farmacon-Il, LLC (Westport, CT)
Application Number:09/712,430
Patent Claim Types:
see list of patent claims
Composition; Formulation; Dosage form; Use;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of a US Patent: A Detailed Analysis

Introduction

When navigating the complex landscape of US patents, understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the intricacies of patent claims, using the example of US Patent 6,342,530, and provide a comprehensive overview of the patent landscape in the United States.

What is a US Patent?

A US patent is a grant of exclusive rights to an inventor for their invention, provided the invention is novel, nonobvious, and sufficiently useful[4].

The Importance of Claim Scope

The claim scope in a patent application is pivotal. It defines the boundaries of what is protected by the patent. A common misconception is that broader claims are better, but this can lead to difficulties in getting the patent allowed and increase the risk of invalidation[3].

Narrow vs. Broad Claims

  • Narrow Claims: These are more specific and closely tied to the embodiments described in the patent specification. They are generally easier to defend and less likely to be invalidated.
  • Broad Claims: While they may seem more desirable, broad claims are harder to get allowed and are at a higher risk of being invalidated due to the abstract idea exception or failure to meet the written description requirement[3].

Patent Claim Types

Patent claims can be categorized into different types, each serving a specific purpose:

Independent Claims

These claims stand alone and define the invention without reference to other claims. They are crucial as they set the broadest scope of the invention.

Dependent Claims

These claims refer back to an independent claim and further limit the scope of the invention. They are used to add specific details or variations to the independent claims.

The Alice Test and Patent Eligibility

The Supreme Court's decision in Alice Corp. v. CLS Bank International introduced a significant framework for determining patent eligibility under 35 U.S.C. § 101. The Alice test involves two steps:

  • Step One: Determine if the claim is directed to an abstract idea.
  • Step Two: If it is, determine if the claim contains an inventive step that transforms the abstract idea into a patent-eligible invention[2].

Example: AI Visualize, Inc. v. Nuance Communications, Inc.

In this case, the district court applied the Alice test and found that the asserted claims were directed to the abstract idea of "retrieving user-requested, remotely stored information" without providing an inventive step. This led to the claims being deemed patent-ineligible[2].

Continuation Applications and Their Impact

Continuation applications can significantly affect the patent landscape. These applications allow inventors to pursue additional claims based on an earlier-filed application.

Types of Continuation Applications

  • Serialized Continuations: These include continuation applications, continuation-in-part applications, and divisional applications. They can result in multiple patents from a single progenitor application[1].
  • Non-Serialized Continuations: These include Request for Continued Examination (RCE) and other similar procedures. They allow applicants to continue the examination process after a final rejection[1].

Probability of Receiving a US Patent

The probability of receiving a US patent varies based on several factors, including the technology field, the size of the entity filing the patent, and the origin of the application.

Measures of Patent Allowance Rates

  • First-Action Allowance Rate: The proportion of progenitor applications allowed without further examination.
  • Progenitor Allowance Rate: The proportion of progenitor applications allowed without any continuation procedure.
  • Family Allowance Rate: The proportion of progenitor applications that produce at least one patent, including outcomes of continuation applications[1].

Technology Fields and Patent Trends

Patent trends vary significantly across different technology fields. For instance:

  • Chemical and Drugs: These fields often have lower allowance rates due to the complexity and specificity of the inventions.
  • Electrical and Electronics: These fields can have higher allowance rates but are also highly competitive[1].

Global and US Patenting Trends

The US patent system is part of a broader global landscape of invention and innovation. Trends in patent applications and grants reflect economic and technological advancements.

US Patenting System

The US patenting system provides detailed data on patent applications and grants by technology area. This data is crucial for understanding the innovation landscape and identifying areas of high activity[4].

The Need for a Small Claims Patent Court

There has been ongoing discussion about the need for a small claims patent court to address the high costs and complexities associated with patent litigation.

ACUS Study

The Administrative Conference of the United States (ACUS) conducted a study on the feasibility and structure of a small claims patent court. This study involved extensive public comments and input from stakeholders to address the legal, policy, and practical considerations[5].

Case Study: US Patent 6,342,530

While the specific details of US Patent 6,342,530 are not provided in the sources, here is a general approach to analyzing any patent:

Claim Analysis

  • Review the independent and dependent claims to understand the scope of the invention.
  • Determine if the claims are broad or narrow and assess the risks associated with each.

Specification and Embodiments

  • Ensure that the claims are anchored to the embodiments described in the specification.
  • Check for any inconsistencies or gaps between the claims and the specification.

Prior Art and Novelty

  • Conduct a thorough search of prior art to ensure the invention is novel and nonobvious.
  • Analyze how the patent distinguishes itself from existing technologies.

Legal and Economic Implications

  • Consider the legal framework, including the Alice test, to ensure patent eligibility.
  • Evaluate the economic implications of the patent, including potential licensing and litigation costs.

Key Takeaways

  • Claim Scope: The scope of patent claims is critical and must be carefully drafted to avoid invalidation risks.
  • Continuation Applications: These can significantly impact the patent landscape and should be used strategically.
  • Patent Eligibility: The Alice test is a crucial framework for determining patent eligibility under 35 U.S.C. § 101.
  • Technology Fields: Patent trends vary across different technology fields, and understanding these trends is essential.
  • Global Trends: The US patent system is part of a global innovation landscape, and trends here reflect broader economic and technological advancements.

FAQs

What is the importance of claim scope in a US patent application?

The claim scope defines the boundaries of what is protected by the patent. Broad claims can be risky as they are harder to get allowed and more likely to be invalidated due to the abstract idea exception or failure to meet the written description requirement[3].

How does the Alice test impact patent eligibility?

The Alice test involves determining if a claim is directed to an abstract idea and if it contains an inventive step that transforms the abstract idea into a patent-eligible invention. This test is crucial for ensuring that patents do not preempt abstract ideas[2].

What are continuation applications, and how do they affect the patent landscape?

Continuation applications allow inventors to pursue additional claims based on an earlier-filed application. They can result in multiple patents from a single progenitor application and complicate the calculation of allowance rates[1].

Why is there a discussion about a small claims patent court?

The discussion is driven by the need to address the high costs and complexities associated with patent litigation. A small claims patent court could provide a more accessible and cost-effective way to resolve patent disputes[5].

How do different technology fields impact patent allowance rates?

Patent allowance rates vary across different technology fields. For example, chemical and drug patents often have lower allowance rates due to their complexity, while electrical and electronics patents may have higher rates but are highly competitive[1].

Sources

  1. What Is the Probability of Receiving a US Patent? - Yale Journal of Law & Technology.
  2. AI VISUALIZE, INC. v. NUANCE COMMUNICATIONS, INC. - US Court of Appeals for the Federal Circuit.
  3. The Importance of Getting the Claim Scope Right in a US Patent Application - Rimon Law.
  4. Invention: U.S. and Comparative Global Trends - National Science Foundation.
  5. U.S. Patent Small Claims Court - Administrative Conference of the United States.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 6,342,530

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 6,342,530

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 293444 ⤷  Subscribe
Canada 2361160 ⤷  Subscribe
Germany 60110185 ⤷  Subscribe
European Patent Office 1205181 ⤷  Subscribe
Japan 2002193799 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.